Multi-isotope calibration for inductively coupled plasma mass spectrometry.

Anal Bioanal Chem

Department of Chemistry, Wake Forest University, Salem Hall, P.O. Box 7486, Winston-Salem, NC, 27109, USA.

Published: January 2018

Multi-isotope calibration (MICal) is a novel approach to calibration for inductively coupled plasma mass spectrometry (ICP-MS). In MICal, only two calibration solutions are required: solution A, composed of 50% v v of sample and 50% v v of a standard solution containing the analytes, and solution B, composed of 50% v v of sample and 50% v v of a blank solution. MICal is based on monitoring the signal intensities of several isotopes of the same analyte in solutions A and B. By plotting the analytical signals from solution A in the x-axis, and from solution B in the y-axis, the analyte concentration in the sample is calculated using the slope of that graph and the concentration of the reference standard added to solution A. As both solutions contain the same amount of sample, matrix-matching is easily achieved. In this proof-of-concept study, MICal was applied to the determination of Ba, Cd, Se, Sn, and Zn in seven certified reference materials with different matrices (e.g., plant materials, flours, and water). In most cases, MICal results presented no statistical difference from the certified values at a 95% confidence level. The new strategy was also compared with traditional calibration methods such as external calibration, internal standardization and standard additions, and recoveries were generally better for MICal. This is a simple, accurate, and fast alternative method for matrix-matching calibration in ICP-MS. Graphical abstract Multi-isotope calibration: fast and innovative matrix-matching calibration for ICP-MS.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00216-017-0753-4DOI Listing

Publication Analysis

Top Keywords

50% v v
16
multi-isotope calibration
12
calibration inductively
8
inductively coupled
8
coupled plasma
8
plasma mass
8
mass spectrometry
8
calibration
8
solution composed
8
composed 50%
8

Similar Publications

Early intraocular lens explantations: 10-year database analysis.

BMC Ophthalmol

July 2024

Department of Ophthalmology, The David J Apple Center for Vision Research, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.

Article Synopsis
  • The study analyzed data from over 2500 intraocular lens (IOL) explantations to determine the causes and characteristics of explantation within the first year after implantation.
  • The study found that 1.9% of IOLs were explanted early, mainly due to dislocation, visual intolerance, opacification, and intraoperative complications, with the fastest explantations occurring due to intraoperative issues.
  • The findings suggest that there are areas for improvement in IOL design and implantation techniques, especially concerning intraoperative damages and early calcification of hydrophilic IOLs.
View Article and Find Full Text PDF

Context: Cardiovascular disease (CVD) is the leading cause of death in the United States. As such, an unmet need exists in the primary and secondary prevention of adverse cardiovascular events (CVEs). Specifically, identifying drugs that can reduce the progression of CVD and serious adverse events is much needed.

View Article and Find Full Text PDF

 Most symptoms of coronavirus 2019 (COVID-19) are mild; however, some patients experience cardiovascular complications, including thromboembolic events and death. Data are needed to better inform prevention and treatment of these events. This analysis was designed to describe patient characteristics, medication use, thromboembolic events, and all-cause mortality in hospitalized COVID-19 patients in the United States.

View Article and Find Full Text PDF

Introduction: The electrophysiological discrimination between fast-slow (F/S-) atrioventricular (AV) nodal reentrant tachycardia (NRT) and atrial tachycardia (AT) originating from the interatrial septum remains challenging. While a V-A-A-V response may occur immediately after ventricular induction or entrainment of either tachycardia, the electrophysiological dissimilarities in that response between the two tachycardias remain unclear. The purpose of this study was to identify a diagnostic indicator discriminating F/S-AVNRT from AT by examining the difference in the V-A-A-V response between the two tachycardias.

View Article and Find Full Text PDF

Surgery for locoregionally advanced head and neck squamous cell carcinoma (HNSCC) results in 30‒50% five-year overall survival. In IMCISION (NCT03003637), a non-randomized phase Ib/IIa trial, 32 HNSCC patients are treated with 2 doses (in weeks 1 and 3) of immune checkpoint blockade (ICB) using nivolumab (NIVO MONO, n = 6, phase Ib arm A) or nivolumab plus a single dose of ipilimumab (COMBO, n = 26, 6 in phase Ib arm B, and 20 in phase IIa) prior to surgery. Primary endpoints are feasibility to resect no later than week 6 (phase Ib) and primary tumor pathological response (phase IIa).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!